<?xml version="1.0" encoding="UTF-8"?>
<p>Thirdly, some HA-head reactive antibodies with undefined epitopes were reported to confer protection 
 <italic>in vivo</italic> via Fc-effector functions. DiLillio et al. demonstrated that the broadly neutralizing HA head-reactive antibodies, 4G05 and 1F05, can induce protection 
 <italic>in vivo</italic> through Fc-FcγR interactions whereas strain-specific HA head reactive antibodies confer protection in an Fc-FcγR interactions-independent manner 
 <italic>in vivo</italic> [
 <xref rid="B100-viruses-12-00276" ref-type="bibr">100</xref>]. In addition, anti-H4 monoclonal antibodies binding to the HA head showed high cross-reactivity to avian and mammalian H4 HAs and protected mice from lethal H4N6 challenges through ADCC activity [
 <xref rid="B81-viruses-12-00276" ref-type="bibr">81</xref>]. Two highly conserved epitopes, designated E1 and E2, located in HA head of a pandemic H1N1 virus, were reported to be recognized by ADCC-Ab [
 <xref rid="B70-viruses-12-00276" ref-type="bibr">70</xref>]. The discovery of HA head reactive antibodies and conserved epitopes may assist the future design of universal vaccines and therapeutics.
</p>
